Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly earnings results on February 12, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.05, beating the consensus estimate of $-0.13 by $0.08 per share. Revenue came in at , meeting the estimate of .
Anebulo Pharmaceuticals's stock moved following the earnings release. The stock currently trades at $0.47 with a market capitalization of $90.8M.